BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21447799)

  • 1. Global phosphoproteomics reveals crosstalk between Bcr-Abl and negative feedback mechanisms controlling Src signaling.
    Rubbi L; Titz B; Brown L; Galvan E; Komisopoulou E; Chen SS; Low T; Tahmasian M; Skaggs B; Müschen M; Pellegrini M; Graeber TG
    Sci Signal; 2011 Mar; 4(166):ra18. PubMed ID: 21447799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells.
    Wu J; Meng F; Lu H; Kong L; Bornmann W; Peng Z; Talpaz M; Donato NJ
    Blood; 2008 Apr; 111(7):3821-9. PubMed ID: 18235045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells.
    Gioia R; Leroy C; Drullion C; Lagarde V; Etienne G; Dulucq S; Lippert E; Roche S; Mahon FX; Pasquet JM
    Blood; 2011 Aug; 118(8):2211-21. PubMed ID: 21730355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259.
    Pene-Dumitrescu T; Peterson LF; Donato NJ; Smithgall TE
    Oncogene; 2008 Nov; 27(56):7055-69. PubMed ID: 18794796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr.
    Warmuth M; Bergmann M; Priess A; Häuslmann K; Emmerich B; Hallek M
    J Biol Chem; 1997 Dec; 272(52):33260-70. PubMed ID: 9407116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase.
    Fan G; Aleem S; Yang M; Miller WT; Tonks NK
    J Biol Chem; 2015 Jun; 290(26):15934-47. PubMed ID: 25897081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.
    Chatain N; Ziegler P; Fahrenkamp D; Jost E; Moriggl R; Schmitz-Van de Leur H; Müller-Newen G
    Oncogene; 2013 Aug; 32(31):3587-97. PubMed ID: 22926520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine.
    Advani G; Lim YC; Catimel B; Lio DSS; Ng NLY; Chüeh AC; Tran M; Anasir MI; Verkade H; Zhu HJ; Turk BE; Smithgall TE; Ang CS; Griffin M; Cheng HC
    Cell Commun Signal; 2017 Aug; 15(1):29. PubMed ID: 28784162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Csk-mediated down-regulation of Src family tyrosine kinases in epidermal growth factor signaling.
    Matsuoka H; Nada S; Okada M
    J Biol Chem; 2004 Feb; 279(7):5975-83. PubMed ID: 14613929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn.
    Barua D; Hlavacek WS; Lipniacki T
    J Immunol; 2012 Jul; 189(2):646-58. PubMed ID: 22711887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells.
    Halbach S; Hu Z; Gretzmeier C; Ellermann J; Wöhrle FU; Dengjel J; Brummer T
    Cell Commun Signal; 2016 Feb; 14():6. PubMed ID: 26912052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells.
    Ptasznik A; Urbanowska E; Chinta S; Costa MA; Katz BA; Stanislaus MA; Demir G; Linnekin D; Pan ZK; Gewirtz AM
    J Exp Med; 2002 Sep; 196(5):667-78. PubMed ID: 12208881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.
    Wu J; Meng F; Kong LY; Peng Z; Ying Y; Bornmann WG; Darnay BG; Lamothe B; Sun H; Talpaz M; Donato NJ
    J Natl Cancer Inst; 2008 Jul; 100(13):926-39. PubMed ID: 18577747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of Csk in signal transduction through the B-cell antigen receptor.
    Hata A; Sabe H; Kurosaki T; Takata M; Hanafusa H
    Mol Cell Biol; 1994 Nov; 14(11):7306-13. PubMed ID: 7935444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
    Jain SK; Langdon WY; Varticovski L
    Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay between the tyrosine kinases Chk and Csk and phosphatase PTPRJ is critical for regulating platelets in mice.
    Nagy Z; Mori J; Ivanova VS; Mazharian A; Senis YA
    Blood; 2020 Apr; 135(18):1574-1587. PubMed ID: 32016283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
    Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
    Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.
    Konig H; Copland M; Chu S; Jove R; Holyoake TL; Bhatia R
    Cancer Res; 2008 Dec; 68(23):9624-33. PubMed ID: 19047139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment.
    Zhang SQ; Yang W; Kontaridis MI; Bivona TG; Wen G; Araki T; Luo J; Thompson JA; Schraven BL; Philips MR; Neel BG
    Mol Cell; 2004 Feb; 13(3):341-55. PubMed ID: 14967142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
    Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
    Front Immunol; 2018; 9():1771. PubMed ID: 30116247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.